|
|
Moreover Technologies - Medical news - 30 of 23778 returned
Moreover Technologies - Real-time news and blogs from thousands of sources
-
Develop Through Targeted Training - Sponsored Link
Ad - Download a white paper about creating effective training & development programs.
-
Insulin inhibits Aβ fibrillogenesis through a decrease of the GM1 ganglioside-rich microdomain in neuronal membranes
J. Neurochem. (2010) 10.1111/j.1471-4159.2010.06620.x Type 2 diabetes is a risk factor for late-onset Alzheimer's disease. However, the underlying mechanisms remain unknown. To investigate whether insulin is associated with the assembly of amyloid
-
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity
J. Neurochem. (2010) 10.1111/j.1471-4159.2010.06622.x Degeneration of locus coeruleus (LC) noradrenergic forebrain projection neurons is an early feature of Alzheimer's disease. The physiological consequences of this phenomenon are unclear, but
-
Tumour necrosis factor alpha induces rapid reduction in AMPA receptor-mediated calcium entry in motor neurones by increasing cell surface expression of the GluR2 subunit: relevance to neurodegeneration
J. Neurochem. (2010) 10.1111/j.1471-4159.2010.06634.x The [alpha]-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor (AMPAR) subunit GluR2, which regulates excitotoxicity and the inflammatory cytokine tumour necrosis factor alpha (TNF[alpha]) have
-
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B ...
Company: Amsterdam Molecular Therapeutics (AMLRF) Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a
-
Symptom clusters and experiences of patients with cancer
karabulu n., erci b., özer n. & özdemir s. (2010) . Journal of Advanced NursingAim. This study is a report of a study to characterize the prevalence and severity of symptoms in patients with cancer and describing the clustering of symptoms.Background.
-
Start of Phase I/II Gene Therapy Clinical Trial for Hemophilia B
/PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT), a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia
-
Malnutrition Common Among Cancer Patients, But Screening Not Routine
FOR INFORMATION CONTACT: Don Jewler, ACCC Communications Director ROCKVILLE, MD – March 10, 2010 – Although malnutrition is common among cancer patients at some point in their treatment, malnutrition screening is not applied to all patients
-
Adolescents and Young Adults with Cancer: Unique Needs Not Fully Met
FOR INFORMATION CONTACT: Don Jewler, ACCC Communications Director ROCKVILLE, MD – March 10, 2010 – Approximately 70,000 adolescents and young adults will develop cancer in the United States each year. Yet their unique needs are not well understood
-
Association of Community Cancer Centers Examines the Business Side of Hospital Cancer Care
FOR INFORMATION CONTACT: Don Jewler, ACCC Communications Director ROCKVILLE, MD – March 10, 2010 – Preliminary results from a survey of community-based cancer programs by the Association of Community Cancer Centers (ACCC) suggest that equipment
|
|
|
|
--> |
![[Valid RSS]](http://arthritishelptips.com/rss/valid-rss.gif "Validate my RSS feed"){kind=small}